Code | 2139A | ||||||||||
MA number | 30/0418/05-S | ||||||||||
Product Form: | tbl flm 42x50 mg (blis.PVC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 30 - ANTIDEPRESSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 11.11.2005 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Sertralin Actavis_09.2024.pdf |
SPC: | SPC_Sertralin Actavis_09.2024.pdf |
Safety feature | Yes |
Data update: | 21.02.2019 |